Enhancing the anticancer effect of androgen deprivation therapy by monocarboxylate transporter 1 inhibitor in prostate cancer cells. Kim J, Park S, Kim S, Ryu S, et al. Prostate 2024 Apr 1. doi: 10.1002/pros.24700.

Read + Share

Amedeo Smart

Independent Medical Education